By Ed Edelson
EmpowHer's HealthDay Reporter
WEDNESDAY, June 4 (HealthDay News) -- A combination of two drugs used to combat some of the damaging effects of type 2 diabetes may also reduce the risk of diabetic kidney failure, a new Danish study has found.
But the researchers warn that testing the combination of losartan (Cozaar) and aliskiren (Tekturna) to block the activity of a molecule that damages renal arteries is still in the early stages.
